ConductScience.org, home

Paper20173776

Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?

Chatenoud L. Nat Rev Endocrinol, 2010. Cited by 76 papers, by iCite.

Cite this record

ConductScience Library. Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies? Papers, record 20173776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20173776

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immune therapy for type 1 diabetes mellitus-what is unique about anti-CD3 antibodies?
PubMed
Journal
Nat Rev Endocrinol
PubMed
Year
2010
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
76
iCite
Relative citation ratio, by iCite
1.69
iCite
Revised in PubMed
2026-10-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chatenoud LLucienne

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
AutoantigensMajor topic
CD3 ComplexMajor topic
Diabetes Mellitus, Type 1Major topic
ImmunotherapyMajor topic
Humans
Models, Biological

Source PubMed

Download CSV of topics

References123

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18482839Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells.J Immunol1993https://conductscience.org/library/papers/8482839PubMed
27694152Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.Nature1993https://conductscience.org/library/papers/7694152PubMed
37589082Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.Eur J Immunol1995https://conductscience.org/library/papers/7589082PubMed
416188950B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients.Rheumatology (Oxford)2005https://conductscience.org/library/papers/16188950PubMed
517389382Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17389382PubMed
612815107Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12815107PubMed
716034144Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice.J Immunol2005https://conductscience.org/library/papers/16034144PubMed
810228190Infliximab for the treatment of fistulas in patients with Crohn's disease.N Engl J Med1999https://conductscience.org/library/papers/10228190PubMed
911722631Suppressor T cells--they're back and critical for regulation of autoimmunity!Immunol Rev2001https://conductscience.org/library/papers/11722631PubMed
1018060033Treatment with CD20-specific antibody prevents and reverses autoimmune diabetes in mice.J Clin Invest2007https://conductscience.org/library/papers/18060033PubMed
111465794Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome.Transplantation1992https://conductscience.org/library/papers/1465794PubMed
129058834CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice.J Immunol1997https://conductscience.org/library/papers/9058834PubMed
1318502302Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study.Lancet2008https://conductscience.org/library/papers/18502302PubMed
1412615891Tolerogenic dendritic cells.Annu Rev Immunol2003https://conductscience.org/library/papers/12615891PubMed
159114038A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.Proc Natl Acad Sci U S A1997https://conductscience.org/library/papers/9114038PubMed
1610990077No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.Diabetologia2000https://conductscience.org/library/papers/10990077PubMed
178402882Following a diabetogenic T cell from genesis through pathogenesis.Cell1993https://conductscience.org/library/papers/8402882PubMed
1817353295beta-cell failure in diabetes and preservation by clinical treatment.Endocr Rev2007https://conductscience.org/library/papers/17353295PubMed
1915032580CD40/CD154 interactions at the interface of tolerance and immunity.Annu Rev Immunol2004https://conductscience.org/library/papers/15032580PubMed
202873396Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.Lancet1986https://conductscience.org/library/papers/2873396PubMed

See all 123 referencesDownload CSV of references

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 76 citations.

PMIDTitleJournalYearIn PapersSource
42540695Combination of proton-pump inhibitor and anti-CD3 F(ab')2 for islet neogenesis and immune modulation in type 1 diabetes.Immunother Adv2026https://conductscience.org/library/papers/42540695PubMed
40158096Anti-CD3 monoclonal antibody in treating patients with type 1 diabetes: an updated systematic review and meta-analysis.Cardiovasc Diabetol2025https://conductscience.org/library/papers/40158096PubMed
37004543Teplizumab: type 1 diabetes mellitus preventable?Eur J Clin Pharmacol2023https://conductscience.org/library/papers/37004543PubMed
36117563Attenuation of inflammation in streptozotocin-induced diabetic rabbits by Matricaria chamomilla oil: A focus on targeting NF-κB and NLRP3 signaling pathways.Chin Herb Med2020https://conductscience.org/library/papers/36117563PubMed
34532981The Detrimental Role of Regulatory T Cells in Nonalcoholic Steatohepatitis.Hepatol Commun2022https://conductscience.org/library/papers/34532981PubMed
33802091Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.Int J Mol Sci2021https://conductscience.org/library/papers/33802091PubMed
32625203Prediabetes Induced by a Single Autoimmune B Cell Clone.Front Immunol2020https://conductscience.org/library/papers/32625203PubMed
30608114Targeting Type 1 Diabetes: Selective Approaches for New Therapies.Biochemistry2019https://conductscience.org/library/papers/30608114PubMed
30227958Loss of Deubiquitinase USP1 Blocks Pancreatic β-Cell Apoptosis by Inhibiting DNA Damage Response.iScience2018https://conductscience.org/library/papers/30227958PubMed
29717116Contrast-enhanced ultrasound measurement of pancreatic blood flow dynamics predicts type 1 diabetes progression in preclinical models.Nat Commun2018https://conductscience.org/library/papers/29717116PubMed
28556921Membrane-bound Dickkopf-1 in Foxp3+ regulatory T cells suppresses T-cell-mediated autoimmune colitis.Immunology2017https://conductscience.org/library/papers/28556921PubMed
27874076Oligofructose as an adjunct in treatment of diabetes in NOD mice.Sci Rep2016https://conductscience.org/library/papers/27874076PubMed
27745778Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain.J Autoimmun2017https://conductscience.org/library/papers/27745778PubMed
27471707Antigen-based immunotherapy for autoimmune disease: current status.Immunotargets Ther2015https://conductscience.org/library/papers/27471707PubMed
26834735Inducing and Administering Tregs to Treat Human Disease.Front Immunol2015https://conductscience.org/library/papers/26834735PubMed
26403950The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.J Autoimmun2016https://conductscience.org/library/papers/26403950PubMed
26313217The case for an autoimmune aetiology of type 1 diabetes.Clin Exp Immunol2016https://conductscience.org/library/papers/26313217PubMed
25241914CD28⁻ CD8⁺ T cells are significantly reduced and correlate with disease duration in juveniles with type 1 diabetes.Hum Immunol2014https://conductscience.org/library/papers/25241914PubMed
24628466Variable immune cell frequencies in peripheral blood of LEW.1AR1-iddm rats over time compared to other congenic LEW strains.Clin Exp Immunol2014https://conductscience.org/library/papers/24628466PubMed
24599515Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes.J Mol Med (Berl)2014https://conductscience.org/library/papers/24599515PubMed

See all 46 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20173776

GET https://conductscience.org/api/papers/v1/20173776/references?page=2